Patient & Public Affairs Manager

Expert for patient governmental & public affairs

Drives public affairs and patient advocacy strategies across international markets, aligning policy priorities

Builds and maintains high-level stakeholder networks (government, patient organizations, media)

Leads cross-functional teams and large-scale campaigns with measurable impact on market access, awareness, and corporate positioning

Open for Consultant & permanent roles

Lead the international patient affairs vision and strategy across Europe and regions outside the US, aligning patient priorities with corporate objectives in rare diseases

Develop and cultivate partnerships with patient groups, policy organizations, professional societies, advocacy leaders, and other external stakeholders to drive international impact

Launched the first international multilingual disease awareness patient portal, expanding patient engagement and education infrastructure globally

Delivered a study, the largest international and first European survey, helping advance disease recognition and support market access in key European markets

Expanded global patient education and outreach through partnerships with medical communications firms, advocacy groups, and key opinion leaders, reaching more than 130,000 people worldwide

Generated insights that informed R&D programs and embedded patient perspective into patient-oriented initiatives

Led public affairs, communications, and patient advocacy strategy for the Oncology Business Unit across lung cancer, multiple myeloma, lymphoma, and leukemia

Built and strengthened partnerships with patient organizations, government stakeholders, media, and medical societies to enhance reputation and support business priorities

Developed and rolled out the updated oncology corporate narrative, increasing recognition in specialized media by 20% year over year

Supported stakeholder engagement on oncology evolution and HTA trends through communications and partnership activity

Led public affairs and government relations programs across EMEA and LATAM, covering the UK, Spain, Germany, Italy, Turkey, Mexico, and Brazil • Built and led the function, managing a direct team of 4 and coordinating more than 20 external PR and lobbying specialists across the region

Directed stakeholder engagement and policy campaigns designed to protect corporate reputation, support business growth, and influence regulatory outcomes

Conducted direct lobbying at national and regional levels to shape regulatory initiatives in priority markets, with estimated business impact of more than 85 million

Managed a public affairs and government relations budget exceeding 3 million

Led government relations strategy and policy shaping initiatives across diabetes, general medicines, nutrition, diagnostics, and medical devices

Represented legislative and regulatory positions to politicians, policymakers, regulators, trade groups, and professional organizations

Protected business interests in matters involving government agencies and policy stakeholders in a complex healthcare environment